ACE Report Cover
No difference between one- and two-injection corticosteroid treatments for trigger finger
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
HAND & WRIST
No difference between one- and two-injection corticosteroid treatments for trigger finger .

A prospective randomized trial comparing the effectiveness of one versus two (staged) corticosteroid injections for the treatment of stenosing tenosynovitis

Hand (N Y). 2014 Sep;9(3):340-5

Ninety-seven adult patients suffering from stenosing tenosynovitis, also known as trigger finger, were randomly allocated to treatment using either two staged corticosteroid injections or a single injection. Disabilities of the Arm, Shoulder and Hand (DASH) scores were used to assess effectiveness of treatment; no significant differences in DASH scores were found between one- and two-injection treatments. Diabetic patients (insulin and non-insulin dependent) who experienced treatment failure prior to 1 year after injection were more likely to require surgical intervention than non-diabetic patients.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. No difference between one- and two-injection corticosteroid treatments for trigger finger. ACE Report. 2015;4(1):7. Available from: https://myorthoevidence.com/AceReport/Show/

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report